AbbVie Inc (ABBV)
176.93
+5.20
(+3.03%)
USD |
NYSE |
Nov 22, 16:00
177.07
+0.14
(+0.08%)
After-Hours: 20:00
AbbVie Cash from Investing (Quarterly): -8.256B for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -8.256B |
| June 30, 2024 | -1.102B |
| March 31, 2024 | -9.588B |
| December 31, 2023 | -800.00M |
| September 30, 2023 | -369.00M |
| June 30, 2023 | -341.00M |
| March 31, 2023 | -499.00M |
| December 31, 2022 | -448.00M |
| September 30, 2022 | 1.286B |
| June 30, 2022 | 130.00M |
| March 31, 2022 | -1.591B |
| December 31, 2021 | -1.145B |
| September 30, 2021 | -615.00M |
| June 30, 2021 | -242.00M |
| March 31, 2021 | -342.00M |
| December 31, 2020 | -627.00M |
| September 30, 2020 | -1.149B |
| June 30, 2020 | -35.65B |
| March 31, 2020 | -129.00M |
| December 31, 2019 | -615.00M |
| September 30, 2019 | 1.378B |
| June 30, 2019 | -140.00M |
| March 31, 2019 | -27.00M |
| December 31, 2018 | -283.00M |
| September 30, 2018 | -963.00M |
| Date | Value |
|---|---|
| June 30, 2018 | 687.00M |
| March 31, 2018 | -447.00M |
| December 31, 2017 | 201.00M |
| September 30, 2017 | -109.00M |
| June 30, 2017 | 318.00M |
| March 31, 2017 | -684.00M |
| December 31, 2016 | -119.00M |
| September 30, 2016 | -199.00M |
| June 30, 2016 | -4.298B |
| March 31, 2016 | -1.458B |
| December 31, 2015 | -297.00M |
| September 30, 2015 | 745.00M |
| June 30, 2015 | -12.51B |
| March 31, 2015 | -873.00M |
| December 31, 2014 | 2.514B |
| September 30, 2014 | -2.284B |
| June 30, 2014 | -359.00M |
| March 31, 2014 | -797.00M |
| December 31, 2013 | 123.00M |
| September 30, 2013 | -964.00M |
| June 30, 2013 | 233.00M |
| March 31, 2013 | 1.487B |
| December 31, 2012 | -206.00M |
| September 30, 2012 | -1.806B |
| June 30, 2012 | -202.00M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-35.65B
Minimum
Jun 2020
1.286B
Maximum
Sep 2022
-3.105B
Average
-615.00M
Median
Dec 2019
Cash from Investing (Quarterly) Benchmarks
| Amgen Inc | -210.00M |
| Johnson & Johnson | -3.128B |
| Eli Lilly and Co | -4.005B |
| Merck & Co Inc | -3.845B |
| Pfizer Inc | -2.057B |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 5.447B |
| Cash from Financing (Quarterly) | -3.072B |
| Free Cash Flow | 15.62B |
| Free Cash Flow Per Share (Quarterly) | 2.933 |
| Free Cash Flow to Equity (Quarterly) | 4.753B |
| Free Cash Flow to Firm (Quarterly) | 5.642B |
| Free Cash Flow Yield | 4.98% |